Dow Jones

38,571.03

-0.30%

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
Acciones
Estados Unidos
NASDAQ
Synergy Pharmaceuticals, Inc. (MM) (SGYPD)
Synergy Pharmaceuticals, Inc. (MM) (SGYPD) Noticias

SGYPD

Synergy Pharmaceuticals, Inc. (MM) (SGYPD)

Synergy Pharmaceuticals, Inc. (MM)

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SGYPD

1

Fecha	Hora	Fuente	Título	Símbolo	Compañía
01/03/2019	18:13	Dow Jones News	Synergy Pharmaceuticals Is Approved to Sell Assets to Bausch Health	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
26/02/2019	18:07	Dow Jones News	Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
17/12/2018	14:43	Dow Jones News	Synergy Pharmaceuticals Up 55% on Trulance Progress in Canada	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	10:10	Dow Jones News	Former Pharma Highflier Appreciates Bathroom Humor -- Overheard	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	07:18	Dow Jones News	Bausch Health to Buy Synergy Pharmaceuticals Out of Bankruptcy for $200 Million--Update	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
12/12/2018	06:14	Dow Jones News	Bausch Health Agrees to Buy Synergy Pharmaceuticals for $200 Million	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
03/01/2012	15:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
27/12/2011	15:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
22/12/2011	05:01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
21/12/2011	11:18	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
19/12/2011	16:04	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3/A)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	15:41	Business Wire	Synergy Pharmaceuticals Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	07:00	PR Newswire (US)	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior V...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
13/12/2011	02:00	Business Wire	Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. & its Chief Scientific Officer & Senior VP of...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
06/12/2011	16:00	Business Wire	Synergy Pharmaceuticals Announces Closing of Public Offering of 1,875,000 Units	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	16:14	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(2) (424B2)	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)
01/12/2011	07:00	Business Wire	Synergy Pharmaceuticals Inc. Announces Pricing of Public Offering of 1,875,000 Units, Listing on NASDAQ & Effectiveness of Re...	NASDAQ:SGYPD	Synergy Pharmaceuticals, Inc. (MM)